EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The impact of BTK knockdown on lung adenocarcinoma growth and immune response

Jilan Huang, Yufan Yuan, Linghong Guo, Guojin Xia iD, Yan Chen, Qi Chen, Min Wang

Cancer Science · 2025

DOI: 10.1111/cas.16394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Jilan Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Research Center For Medical Imaging In Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the molecular role of the BTK gene in lung adenocarcinoma (LUAD) progression and patient prognosis. Using a radiomics model based on BTK expression and PET‐CT data analyzed through DeeplabV3, alongside transcriptomic and clinical data from TCGA, we established a strong predictive relationship between BTK levels and LUAD outcomes. Our findings demonstrate that low BTK expression is linked to poorer prognoses. Experimental models, including cell lines and in vivo mouse studies, revealed that BTK deficiency leads to increased LUAD cell proliferation, invasion, and metastasis. Furthermore, in vivo models indicated that BTK knockdown results in enhanced tumor growth and diminished CD8+ T cell activity. These results suggest that BTK plays a crucial role in modulating LUAD progression and the tumor immune environment, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseAdenocarcinoma of LungLung NeoplasmsAnimalsHumansMiceCell ProliferationCell Line, TumorCD8-Positive T-LymphocytesGene Knockdown TechniquesPrognosisFemaleGene Expression Regulation, NeoplasticTumor MicroenvironmentMalePositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

BTK geneCD8+ T cellsPET‐CTlung adenocarcinomaradiomics modeltranscriptomics

Substanzen

Agammaglobulinaemia Tyrosine KinaseBTK protein, human

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Jiangxi Province Medical Imaging Research Institute, Nanchang, China.

ORCID-Profile: Guojin Xia

Förderung

  • National Natural Science Foundation of China
  • Clinical Research Center For Medical Imaging In Jiangxi Province

Zitieren

APA

Huang, J., Yuan, Y., Guo, L., Xia, G., Chen, Y., Chen, Q., & Wang, M. (2025). The impact of BTK knockdown on lung adenocarcinoma growth and immune response. Cancer Science. https://doi.org/10.1111/cas.16394

Vancouver

Huang J, Yuan Y, Guo L, Xia G, Chen Y, Chen Q, et al. The impact of BTK knockdown on lung adenocarcinoma growth and immune response. Cancer Science. 2025. doi:10.1111/cas.16394

BibTeX
@article{Huang2025,
  author = {Huang, Jilan and Yuan, Yufan and Guo, Linghong and Xia, Guojin and Chen, Yan and Chen, Qi and Wang, Min},
  title = {The impact of BTK knockdown on lung adenocarcinoma growth and immune response},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16394}
}
Kostenlos starten →